Vnitr Lek 2025, 71(5):321-325

Complete atrioventricular block as a manifestation of Lyme carditis

Ivana Čapková
Interní oddělení SZZ Krnov

Lyme disease is a common infection with multi-systemic manifestations. In some patients, it may be asymptomatic, but in symptomatic cases, the most frequent manifestation is a skin lesion known as erythema migrans. In a small percentage of cases, the infection presents as Lyme carditis. The symptoms of Lyme carditis include fatigue, syncope, palpitations, and dyspnea. These symptoms are most often caused by cardiac conduction system disorders. The main risk of Lyme carditis is rapid progression of conduction abnormalities, the development of malignant arrhythmias, and sudden cardiac death. Suspicion of Lyme-associated carditis should prompt immediate diagnostic evaluation, patient observation and monitoring, and the initiation of antibiotic therapy without any delay. In some cases, temporary cardiac pacing may be required.

Keywords: lyme disease, lyme carditis, third-degree atrioventricular block.

Accepted: August 25, 2025; Published: September 18, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Čapková I. Complete atrioventricular block as a manifestation of Lyme carditis. Vnitr Lek. 2025;71(5):321-325.
Download citation

References

  1. Burn L, Tran TMP, Pilz A, et al. Incidence of Lyme Borreliosis in Europe from National Surveillance Systems (2005-2020). Vector Borne Zoonotic Dis. 2023;23(4):156-171. Go to original source... Go to PubMed...
  2. Kostić T, Momčilović S, Perišić ZD, et al. Manifestations of Lyme carditis. Int J Cardiol. 2017;232:24-32. Go to original source... Go to PubMed...
  3. Orlíková H, et al. Lymeská borrelióza v České republice: roční zpráva o epidemiologické situaci za rok 2018. Zprávy Centra epidemiologie a mikrobiologie (SZÚ, Praha). 2019;28(11-12):453-458.
  4. Radesich C, Del Mestre E, Medo K, et al. Lyme Carditis: From Pathophysiology to Clinical Management. Pathogens. 2022;11(5):582. Go to original source... Go to PubMed...
  5. Muehlenbachs A, Bollweg BC, Schulz TJ, et al. Cardiac Tropism of Borrelia burgdorferi: An Autopsy Study of Sudden Cardiac Death Associated with Lyme Carditis. Am J Pathol. 2016;186(5):1195-1205. Go to original source... Go to PubMed...
  6. Bartůněk P, et al. Lymeská borelióza. 4. přeprac. vyd. Praha: Grada; 2013.
  7. Paim AC, Baddour LM, Pritt BS, et al. Lyme Endocarditis. Am J Med. 2018;131(9):1126-1129. Go to original source... Go to PubMed...
  8. Kwit NA, Nelson CA, Max R, et al. Risk Factors for Clinician-Diagnosed Lyme Arthritis, Facial Palsy, Carditis, and Meningitis in Patients From High-Incidence States. Open Forum Infect Dis. 2017;5(1):ofx254. Go to original source... Go to PubMed...
  9. Wamboldt R, Wang CN, Miller JC, et al. Pacemaker Explantation in Patients With Lyme Carditis. JACC Case Rep. 2022;4(10):613-616. Go to original source... Go to PubMed...
  10. Uzomah UA, Rozen G, Hosseini SM, et al. Incidence of carditis and predictors of pacemaker implantation in patients hospitalized with Lyme disease. PLoS One. 2021;16(11):e0259123. Go to original source... Go to PubMed...
  11. Yoon EC, Vail E, Kleinman G, et al. Lyme disease: a case report of a 17-year-old male with fatal Lyme carditis. Cardiovasc Pathol. 2015;24(5):317-321. Go to original source... Go to PubMed...
  12. Bruyn GA, De Koning J, Reijsoo FJ, et al. Lyme pericarditis leading to tamponade. Br J Rheumatol. 1994;33(9):862-866. Go to original source... Go to PubMed...
  13. Scheffold N, Herkommer B, Kandolf R, et al. Lyme carditis--diagnosis, treatment and prognosis. Dtsch Arztebl Int. 2015;112(12):202-208. Go to original source... Go to PubMed...
  14. Branda JA, Steere AC. Laboratory Diagnosis of Lyme Borreliosis. Clin Microbiol Rev. 2021;34(2):e00018-19. Go to original source... Go to PubMed...
  15. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis, and Treatment of Lyme Disease. Arthritis Care Res (Hoboken). 2021;73(1):1-9. Go to original source... Go to PubMed...
  16. Angulo FJ, Colby E, Lebech AM, et al. Incidence of symptomatic Lyme borreliosis in nine European countries. Int J Infect Dis. 2024;149:107242. Go to original source... Go to PubMed...
  17. Gudowska-Sawczuk M, Mroczko B. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance. Int J Mol Sci. 2020;21(8):2927. Go to original source... Go to PubMed...
  18. Masouris I, Klein M, Ködel U. The potential for CXCL13 in CSF as a differential diagnostic tool in central nervous system infection. Expert Rev Anti Infect Ther. 2020;18(9):875-885. Go to original source... Go to PubMed...
  19. Besant G, Wan D, Yeung C, et al. Suspicious index in Lyme carditis: Systematic review and proposed new risk score. Clin Cardiol. 2018;41(12):1611-1616. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.